{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":""},{"Key":"CEHoursPP8","Value":""},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":""},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"3"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":"","ContentCaptureVendorSpecification":null,"Created":null,"Date":"2022-04-12","Description":"<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\"><i><span style=\"background:white\"><span style=\"color:#201f1e\">Development of a multitargeted therapy for prostate cancer<\/span><\/span><\/i><\/span><\/span><\/span><\/p>\u000a\u000a<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\">To enable the development of multitargeted therapeutics for prostate cancer, we have developed an unbiased RNA interference (RNAi) based negative selection screen to identify shRNAs that cause toxicity in cellular models of relapsed disease after androgen deprivation therapy. Results indicate the value of this screen for the identification of effective multitarget therapeutic modalities.<\/span><\/span><\/span><\/p>\u000a\u000a<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\"><b>Speaker: Maria J. Ruiz-Echevarria<\/b><\/span><\/span><\/span><\/p>\u000a\u000a<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\"><i>Immunophenotyping of TCR and BCR clonotypes<\/i><\/span><\/span><\/span><\/p>\u000a\u000a<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\">T-cell receptor (TCR) and B-cell receptor (BCR) repertoire profiling holds great potential for understanding disease mechanisms and for the development of new therapeutics. To facilitate these studies, we developed a novel technology for combined profiling of all human TCR and BCR variable regions and phenotypic characterization of immune cells.<\/span><\/span><\/span><\/p>\u000a\u000a<p style=\"margin-bottom:11px\"><span style=\"font-size:11pt\"><span style=\"line-height:107%\"><span style=\"font-family:Calibri,sans-serif\"><b>Speaker: Alex Chenchik<\/b><\/span><\/span><\/span><\/p>\u000a","Duration":60,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/12\/2022 4:00:00 PM","EndTime":"16:00","HidePresentationRating":"False","HidePresentations":"False","Id":"832","Key":"2aab58ef-89da-4cb0-b441-c74bce86e9db","LastUpdated":"2022-03-25 12:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"Spotlight Theater A, Halls D-H","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"ESP26","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Incomplete","SearchResultBody":"ESP26. Cellecta, Inc.: CRISPR & RNAi Genetic Screening and other Methods for the Discovery of Oncogenic Vulnerabilities and Drug Resistance","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"Spotlight Theater A, Halls D-H","SearchResultHeader":"Apr 12 2022  3:00PM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/12\/2022 3:00:00 PM","StartTime":"15:00","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Cellecta, Inc.: CRISPR & RNAi Genetic Screening and other Methods for the Discovery of Oncogenic Vulnerabilities and Drug Resistance","Type":null,"TypeKey":null}